National Union Fire Insurance Co
If your package arrives damaged or if temperature indicators suggest exposure to heat, do not use the medicationcontact PlexusDx customer support with photos of the packaging, and a replacement will be sent at no extra cost
Maharjan R, Lim DS, Baik HJ, Park HE, Kim M-S, Kim KH, Jeong SH
Dosing Protocol Key Efficacy Data The SURMOUNT clinical trial program established tirzepatide as the most effective GLP-1 weight loss agent currently available: SURMOUNT-1 (adults without diabetes): Mean weight loss of 20.9% (10 mg), 24.0% (15 mg) at 72 weeks versus 3.1% placebo (Jastreboff et al., NEJM , 2022) SURMOUNT-2 (adults with type 2 diabetes): Mean weight loss of 12.8% (10 mg), 14.7% (15 mg) at 72 weeks (Garvey et al., Lancet , 2023) SURMOUNT-3 (after intensive lifestyle intervention lead-in): Mean total weight loss of 26.6% with tirzepatide 15 mg (Wadden et al., Nature Medicine , 2023) SURMOUNT-4 (withdrawal study): Patients who discontinued tirzepatide after 36 weeks regained approximately two-thirds of lost weight by week 88, demonstrating the chronic disease nature of obesity and the need for ongoing treatment (Aronne et al., JAMA , 2024) Why Dual Agonism Matters The GIP receptor activation in tirzepatide produces additive effects beyond GLP-1 agonism alone
When a trigger or root cause factor, such as a toxin or infection, permeates through a leaky gut and attacks the thyroid cells, the thyroid will respond by sending out a stress signal
primary-cta Is Orlistat Worth the Cost
